Use the Back button in your browser to see the other results of your search or to select another record.
Randomized trial of weight loss in primary breast cancer: impact on body composition, circulating biomarkers and tumor characteristics [with consumer summary] |
Demark-Wahnefried W, Rogers LQ, Gibson JT, Harada S, Fruge AD, Oster RA, Grizzle WE, Norian LA, Yang ES, della Manna D, Jones LW, Azrad M, Krontiras H |
International Journal of Cancer 2020 May 15;146(10):2784-2796 |
clinical trial |
7/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: Yes; Adequate follow-up: Yes; Intention-to-treat analysis: Yes; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
Copyright release for this abstract has not been granted.
|